Literature DB >> 20830743

Sorting nexin 6 interacts with breast cancer metastasis suppressor-1 and promotes transcriptional repression.

José Rivera1, Diego Megías, Jerónimo Bravo.   

Abstract

Sorting nexin 6 (SNX6), a predominantly cytoplasmic protein involved in intracellular trafficking of membrane receptors, was identified as a TGF-β family interactor. However, apart from being a component of the Retromer, little is known about SNX6 cellular functions. Pim-1-dependent SNX6 nuclear translocation has been reported suggesting a putative nuclear role for SNX6. Here, we describe a previously non-reported association of SNX6 with breast cancer metastasis suppressor 1 (BRMS1) protein detected by a yeast two-hybrid screening. The interaction can be reconstituted in vitro and further FRET analysis confirmed the novel interaction. Additionally, we identified their coiled-coil domains as the minimal binding motives required for interaction. Since BRMS1 has been shown to repress transcription, we sought the ability of SNX6 to interfere with this nuclear activity. Using a standard gene reporter assay, we observed that SNX6 increases BRMS1-dependent transcriptional repression. Moreover, over-expression of SNX6 was capable of diminishing trans-activation in a dose-dependent manner.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20830743     DOI: 10.1002/jcb.22874

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  9 in total

1.  Sorting nexin 5 and dopamine d1 receptor regulate the expression of the insulin receptor in human renal proximal tubule cells.

Authors:  Fengmin Li; Jian Yang; John Edward Jones; Van Anthony M Villar; Peiying Yu; Ines Armando; Robin A Felder; Pedro A Jose
Journal:  Endocrinology       Date:  2015-03-31       Impact factor: 4.736

2.  Sorting nexin 6 interacts with Cullin3 and regulates programmed death ligand 1 expression.

Authors:  Chinmoy Ghosh; Yanli Xing; Suhua Li; Rosalie G Hoyle; Ming Sun; Jiong Li; Yue Sun
Journal:  FEBS Lett       Date:  2021-09-19       Impact factor: 3.864

3.  Identification of specific role of SNX family in gastric cancer prognosis evaluation.

Authors:  Beibei Hu; Guohui Yin; Xuren Sun
Journal:  Sci Rep       Date:  2022-06-17       Impact factor: 4.996

4.  The isolated C-terminal nuclear localization sequence of the breast cancer metastasis suppressor 1 is disordered.

Authors:  David Pantoja-Uceda; José L Neira; Lellys M Contreras; Christa A Manton; Danny R Welch; Bruno Rizzuti
Journal:  Arch Biochem Biophys       Date:  2019-01-30       Impact factor: 4.013

5.  Down-regulation of SNX1 predicts poor prognosis and contributes to drug resistance in colorectal cancer.

Authors:  Zehua Bian; Yuyang Feng; Yao Xue; Yaling Hu; Qifeng Wang; Leyuan Zhou; Zhihui Liu; Jiwei Zhang; Yuan Yin; Bing Gu; Zhaohui Huang
Journal:  Tumour Biol       Date:  2015-12-07

6.  RNA-Seq gene profiling--a systematic empirical comparison.

Authors:  Nuno A Fonseca; John Marioni; Alvis Brazma
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

7.  Identifying Methylation Pattern and Genes Associated with Breast Cancer Subtypes.

Authors:  Lei Chen; Tao Zeng; Xiaoyong Pan; Yu-Hang Zhang; Tao Huang; Yu-Dong Cai
Journal:  Int J Mol Sci       Date:  2019-08-31       Impact factor: 5.923

8.  Perturbation of BRMS1 interactome reveals pathways that impact metastasis.

Authors:  Rosalyn C Zimmermann; Mihaela E Sardiu; Christa A Manton; Md Sayem Miah; Charles A S Banks; Mark K Adams; Devin C Koestler; Douglas R Hurst; Mick D Edmonds; Michael P Washburn; Danny R Welch
Journal:  PLoS One       Date:  2021-11-17       Impact factor: 3.752

9.  The C-terminal putative nuclear localization sequence of breast cancer metastasis suppressor 1, BRMS1, is necessary for metastasis suppression.

Authors:  Douglas R Hurst; Yi Xie; John W Thomas; Jianzhong Liu; Mick D Edmonds; Mark D Stewart; Danny R Welch
Journal:  PLoS One       Date:  2013-02-04       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.